DK2256494T3 - System for monitoring physiological characteristics according to the user's biological condition - Google Patents
System for monitoring physiological characteristics according to the user's biological condition Download PDFInfo
- Publication number
- DK2256494T3 DK2256494T3 DK10177011.3T DK10177011T DK2256494T3 DK 2256494 T3 DK2256494 T3 DK 2256494T3 DK 10177011 T DK10177011 T DK 10177011T DK 2256494 T3 DK2256494 T3 DK 2256494T3
- Authority
- DK
- Denmark
- Prior art keywords
- alarm
- user
- glucose
- blood glucose
- monitor
- Prior art date
Links
- 238000012544 monitoring process Methods 0.000 title claims description 56
- 238000005259 measurement Methods 0.000 claims abstract description 106
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 295
- 239000008103 glucose Substances 0.000 claims description 295
- 210000004369 blood Anatomy 0.000 claims description 117
- 239000008280 blood Substances 0.000 claims description 117
- 208000013016 Hypoglycemia Diseases 0.000 claims description 61
- 230000008859 change Effects 0.000 claims description 35
- 230000002618 waking effect Effects 0.000 claims description 10
- 230000003247 decreasing effect Effects 0.000 claims description 8
- 230000004913 activation Effects 0.000 claims description 7
- 230000006870 function Effects 0.000 description 78
- 230000002218 hypoglycaemic effect Effects 0.000 description 65
- 201000001421 hyperglycemia Diseases 0.000 description 35
- 230000003345 hyperglycaemic effect Effects 0.000 description 34
- 238000001802 infusion Methods 0.000 description 33
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 24
- 238000000034 method Methods 0.000 description 23
- 238000004891 communication Methods 0.000 description 18
- 239000003814 drug Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- 229940079593 drug Drugs 0.000 description 15
- 230000002641 glycemic effect Effects 0.000 description 14
- 238000003825 pressing Methods 0.000 description 14
- 230000001960 triggered effect Effects 0.000 description 13
- 102000004877 Insulin Human genes 0.000 description 12
- 108090001061 Insulin Proteins 0.000 description 12
- 229940125396 insulin Drugs 0.000 description 12
- 230000000007 visual effect Effects 0.000 description 11
- 230000005540 biological transmission Effects 0.000 description 10
- 206010056997 Impaired fasting glucose Diseases 0.000 description 9
- 230000003466 anti-cipated effect Effects 0.000 description 9
- 238000004364 calculation method Methods 0.000 description 9
- 238000009826 distribution Methods 0.000 description 9
- 238000012552 review Methods 0.000 description 9
- 238000012790 confirmation Methods 0.000 description 8
- 230000000875 corresponding effect Effects 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 8
- 230000000422 nocturnal effect Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 230000037147 athletic performance Effects 0.000 description 7
- 238000009499 grossing Methods 0.000 description 7
- 230000003213 activating effect Effects 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 230000001934 delay Effects 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 230000006399 behavior Effects 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 238000007920 subcutaneous administration Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 239000010409 thin film Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000009471 action Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 230000004397 blinking Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 238000012806 monitoring device Methods 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 239000011295 pitch Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 230000008054 signal transmission Effects 0.000 description 3
- 230000001360 synchronised effect Effects 0.000 description 3
- 206010000210 abortion Diseases 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000009529 body temperature measurement Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 230000000246 remedial effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101100156608 Mus musculus Vwde gene Proteins 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241000876466 Varanus bengalensis Species 0.000 description 1
- 241000439496 Varanus dumerilii Species 0.000 description 1
- 241000857212 Varanus nebulosus Species 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- AZEVAJBARUDLQQ-BTVCFUMJSA-N formic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O AZEVAJBARUDLQQ-BTVCFUMJSA-N 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000009474 immediate action Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000009894 physiological stress Effects 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 230000007363 regulatory process Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48785—Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
- G01N33/48792—Data management, e.g. communication with processing unit
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0242—Operational features adapted to measure environmental factors, e.g. temperature, pollution
- A61B2560/0247—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value
- A61B2560/0252—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value using ambient temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0443—Modular apparatus
- A61B2560/045—Modular apparatus with a separable interface unit, e.g. for communication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Optics & Photonics (AREA)
- Heart & Thoracic Surgery (AREA)
- Databases & Information Systems (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Data Mining & Analysis (AREA)
- Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Human Computer Interaction (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Artificial Intelligence (AREA)
- Emergency Medicine (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/860,114 US7399277B2 (en) | 2001-12-27 | 2004-06-03 | System for monitoring physiological characteristics |
| EP05755120A EP1759201B1 (en) | 2004-06-03 | 2005-05-20 | System for monitoring physiological characteristics according to the user biological state |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2256494T3 true DK2256494T3 (en) | 2017-04-10 |
Family
ID=37684661
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10177011.3T DK2256494T3 (en) | 2004-06-03 | 2005-05-20 | System for monitoring physiological characteristics according to the user's biological condition |
| DK10178251.4T DK2259057T3 (en) | 2004-06-03 | 2005-05-20 | System for monitoring physical characteristics depending on the user's physical condition |
| DK10178254.8T DK2256495T3 (en) | 2004-06-03 | 2005-05-20 | A system for monitoring the physical characteristics according to a user's biological status |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10178251.4T DK2259057T3 (en) | 2004-06-03 | 2005-05-20 | System for monitoring physical characteristics depending on the user's physical condition |
| DK10178254.8T DK2256495T3 (en) | 2004-06-03 | 2005-05-20 | A system for monitoring the physical characteristics according to a user's biological status |
Country Status (6)
| Country | Link |
|---|---|
| EP (4) | EP2259057B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5594935B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE484745T1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2816310C (cg-RX-API-DMAC7.html) |
| DE (1) | DE602005024133D1 (cg-RX-API-DMAC7.html) |
| DK (3) | DK2256494T3 (cg-RX-API-DMAC7.html) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7647202B2 (en) * | 2006-07-05 | 2010-01-12 | Arizona Public Service Company | Method for exception-based notification of the condition of an apparatus |
| JP4800373B2 (ja) * | 2007-12-12 | 2011-10-26 | パナソニック株式会社 | 生体試料測定装置 |
| IL197532A0 (en) * | 2008-03-21 | 2009-12-24 | Lifescan Scotland Ltd | Analyte testing method and system |
| JP2009244006A (ja) * | 2008-03-31 | 2009-10-22 | Dkk Toa Corp | イオン濃度の変化量を示す測定装置 |
| WO2010135646A1 (en) | 2009-05-22 | 2010-11-25 | Abbott Diabetes Care Inc. | Usability features for integrated insulin delivery system |
| EP4576110A3 (en) | 2009-08-31 | 2025-09-17 | Abbott Diabetes Care Inc. | Displays for a medical device |
| RU2012112589A (ru) * | 2009-09-02 | 2013-10-10 | Юниверсити Оф Вирджиния Пэйтент Фаундейшн | Отслеживание вероятности приближающейся гипогликемии при диабете на основе данных самостоятельного контроля глюкозы в крови |
| CA3077994C (en) * | 2009-09-29 | 2022-06-21 | Lifescan Scotland Limited | Analyte testing method and device for diabetes management |
| JP5909037B2 (ja) | 2009-10-07 | 2016-04-26 | 日本光電工業株式会社 | アラーム優先度の変更機能付き生体情報モニタ装置及びアラーム制御方法 |
| JP5083297B2 (ja) * | 2009-11-18 | 2012-11-28 | セイコーエプソン株式会社 | 予測血糖値算出装置、予測血糖値算出方法およびプログラム |
| ES2528705T3 (es) | 2010-02-25 | 2015-02-11 | Lifescan Scotland Limited | Procedimiento y sistema de prueba de analitos con notificación de tendencias de glucemia alta y baja |
| CN102883656A (zh) * | 2010-03-31 | 2013-01-16 | 安尼马斯公司 | 用于显示分析物传感器数据的方法和系统 |
| US20120130646A1 (en) * | 2010-11-19 | 2012-05-24 | Lifescan, Inc. | Analyte testing method and system with high and low analyte trends notification |
| US9033877B2 (en) * | 2011-02-23 | 2015-05-19 | Roche Diabetes Care, Inc. | Device and method for determining blood glucose characteristics |
| MX346058B (es) * | 2011-04-14 | 2017-03-06 | Koninklijke Philips Nv | Metodo de alarma gradual para monitores de pacientes. |
| JP5653469B2 (ja) * | 2012-03-30 | 2015-01-14 | アークレイ株式会社 | 測定装置および測定システム |
| US9119529B2 (en) | 2012-10-30 | 2015-09-01 | Dexcom, Inc. | Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered |
| WO2014093021A1 (en) * | 2012-12-12 | 2014-06-19 | Edwards Lifesciences Corporation | System for controlling presentation of an estimated analyte value |
| US9801541B2 (en) * | 2012-12-31 | 2017-10-31 | Dexcom, Inc. | Remote monitoring of analyte measurements |
| US9730621B2 (en) | 2012-12-31 | 2017-08-15 | Dexcom, Inc. | Remote monitoring of analyte measurements |
| US9636070B2 (en) | 2013-03-14 | 2017-05-02 | DePuy Synthes Products, Inc. | Methods, systems, and devices for monitoring and displaying medical parameters for a patient |
| CN105308603B (zh) | 2013-06-13 | 2019-04-19 | 豪夫迈·罗氏有限公司 | 用于结合连续测量的血糖值的模式的特性监视的方法和装置以及计算机存储介质 |
| EP2851824A1 (en) | 2013-09-20 | 2015-03-25 | Sanofi-Aventis Deutschland GmbH | Data management unit for supporting health control |
| EP2851823A1 (en) | 2013-09-20 | 2015-03-25 | Sanofi-Aventis Deutschland GmbH | Data management unit for supporting health control |
| JP6855244B2 (ja) | 2013-10-31 | 2021-04-07 | デックスコム・インコーポレーテッド | 連続的監視デバイスのための適応型インターフェース |
| EP3437558B1 (en) * | 2014-04-10 | 2024-11-27 | DexCom, Inc. | Glycemic urgency assessment and alerts interface |
| AU2015302025B2 (en) * | 2014-08-11 | 2021-08-19 | The Regents Of The University Of California | Continuous analyte sensor |
| JP6855371B2 (ja) * | 2014-10-22 | 2021-04-07 | デックスコム・インコーポレーテッド | 連続的グルコース監視のためのユーザインターフェース |
| JP6622478B2 (ja) * | 2015-03-31 | 2019-12-18 | 日本光電工業株式会社 | 医療機器、及び医療システム |
| JP6685664B2 (ja) * | 2015-07-10 | 2020-04-22 | パラマウントベッド株式会社 | 患者状態通報装置、患者状態通報システム及び患者状態通報装置における通報方法 |
| US10413254B2 (en) | 2016-07-08 | 2019-09-17 | General Electric Company | Dynamic automated adjustment of alarm threshold levels |
| US9852265B1 (en) * | 2016-09-30 | 2017-12-26 | General Electric Company | System and method of medical device alarm management |
| EP4492399A3 (en) | 2018-05-04 | 2025-03-26 | Insulet Corporation | Safety constraints for a control algorithm-based drug delivery system |
| US10720029B1 (en) | 2019-02-05 | 2020-07-21 | Roche Diabetes Care, Inc. | Medical device alert, optimization, personalization, and escalation |
| US12241796B2 (en) * | 2019-02-26 | 2025-03-04 | Seasight Technologies Ltd | Thermometer patch and methods |
| WO2020263706A1 (en) * | 2019-06-27 | 2020-12-30 | Eli Lilly And Company | Systems and methods for detecting missed bolus doses |
| CN112444634A (zh) * | 2019-08-30 | 2021-03-05 | 深圳迈瑞生物医疗电子股份有限公司 | 一种样本分析装置及其报警方法 |
| CN112107802A (zh) * | 2020-09-03 | 2020-12-22 | 浙江省肿瘤医院 | 无线式放射治疗机房病人生命体征监测和报警装置 |
| US20220248988A1 (en) * | 2020-09-17 | 2022-08-11 | Abbott Diabetes Care Inc. | Digital and user interfaces for analyte monitoring systems |
| KR102569413B1 (ko) * | 2020-12-14 | 2023-08-24 | 주식회사 아이센스 | 생체 정보를 연속하여 측정하는 신체 부착 장치 |
| GB2607265A (en) * | 2021-03-31 | 2022-12-07 | The Flame Lily Holdings Ltd | Outputting a notification |
| KR102745732B1 (ko) * | 2021-12-29 | 2024-12-24 | 주식회사 아이센스 | 교정 알람 방법 |
| KR102797488B1 (ko) * | 2021-12-31 | 2025-04-22 | 주식회사 아이센스 | 교정 알람 방법 |
| CN119092142B (zh) * | 2024-11-07 | 2025-01-21 | 安徽中医药大学第一附属医院 | 一种呼吸道传染病的早期医疗信息辅助挖掘方法 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4573994A (en) | 1979-04-27 | 1986-03-04 | The Johns Hopkins University | Refillable medication infusion apparatus |
| US4562751A (en) | 1984-01-06 | 1986-01-07 | Nason Clyde K | Solenoid drive apparatus for an external infusion pump |
| US4678408A (en) | 1984-01-06 | 1987-07-07 | Pacesetter Infusion, Ltd. | Solenoid drive apparatus for an external infusion pump |
| US4685903A (en) | 1984-01-06 | 1987-08-11 | Pacesetter Infusion, Ltd. | External infusion pump apparatus |
| US5299571A (en) | 1993-01-22 | 1994-04-05 | Eli Lilly And Company | Apparatus and method for implantation of sensors |
| US5497772A (en) | 1993-11-19 | 1996-03-12 | Alfred E. Mann Foundation For Scientific Research | Glucose monitoring system |
| US5390671A (en) | 1994-03-15 | 1995-02-21 | Minimed Inc. | Transcutaneous sensor insertion set |
| US5391250A (en) | 1994-03-15 | 1995-02-21 | Minimed Inc. | Method of fabricating thin film sensors |
| US5482473A (en) | 1994-05-09 | 1996-01-09 | Minimed Inc. | Flex circuit connector |
| US5586553A (en) | 1995-02-16 | 1996-12-24 | Minimed Inc. | Transcutaneous sensor insertion set |
| US6558351B1 (en) | 1999-06-03 | 2003-05-06 | Medtronic Minimed, Inc. | Closed loop system for controlling insulin infusion |
| US6579690B1 (en) * | 1997-12-05 | 2003-06-17 | Therasense, Inc. | Blood analyte monitoring through subcutaneous measurement |
| US7647237B2 (en) | 1998-04-29 | 2010-01-12 | Minimed, Inc. | Communication station and software for interfacing with an infusion pump, analyte monitor, analyte meter, or the like |
| US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US6554798B1 (en) | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
| US6558320B1 (en) | 2000-01-20 | 2003-05-06 | Medtronic Minimed, Inc. | Handheld personal data assistant (PDA) with a medical device and method of using the same |
| DK1413245T3 (da) | 1998-10-08 | 2011-10-10 | Medtronic Minimed Inc | Anlæg til overvågning af et kendetegn ved fjernmåling |
| FI115289B (fi) * | 2000-02-23 | 2005-04-15 | Polar Electro Oy | Elimistön energia-aineenvaihdunnan ja glukoosin määrän mittaaminen |
| US6895263B2 (en) | 2000-02-23 | 2005-05-17 | Medtronic Minimed, Inc. | Real time self-adjusting calibration algorithm |
| JP2003533318A (ja) * | 2000-05-25 | 2003-11-11 | ヘルセテック インコーポレイテッド | 手首に取りつけられた装置を用いる生理的な監視 |
| WO2002044865A2 (en) * | 2000-10-27 | 2002-06-06 | Digital Angel Corporation | Systems and methods for monitoring and tracking related u.s. patent applications |
| WO2003001337A2 (en) * | 2001-06-22 | 2003-01-03 | Sekura Ronald D | Prescription compliance device and method of using device |
| US20030208113A1 (en) * | 2001-07-18 | 2003-11-06 | Mault James R | Closed loop glycemic index system |
| JP3538399B2 (ja) * | 2001-08-21 | 2004-06-14 | コーリンメディカルテクノロジー株式会社 | 患者監視装置 |
| WO2003045233A1 (en) | 2001-11-21 | 2003-06-05 | Optiscan Biomedical Corporation | Method and apparatus for improving the accuracy of alternative site analyte concentration measurements |
| US20050027182A1 (en) * | 2001-12-27 | 2005-02-03 | Uzair Siddiqui | System for monitoring physiological characteristics |
| US7022072B2 (en) * | 2001-12-27 | 2006-04-04 | Medtronic Minimed, Inc. | System for monitoring physiological characteristics |
| JP3872371B2 (ja) * | 2002-03-29 | 2007-01-24 | セイコーインスツル株式会社 | 携帯型生体情報収集装置、生体情報収集システム及び生体情報収集方法 |
| US7278983B2 (en) | 2002-07-24 | 2007-10-09 | Medtronic Minimed, Inc. | Physiological monitoring device for controlling a medication infusion device |
| US20040068230A1 (en) | 2002-07-24 | 2004-04-08 | Medtronic Minimed, Inc. | System for providing blood glucose measurements to an infusion device |
| US9921703B2 (en) | 2012-11-27 | 2018-03-20 | Guardian Glass, LLC | Transparent conductive coating for capacitive touch panel with additional functional film(s) |
| US9496283B1 (en) | 2015-08-10 | 2016-11-15 | Stmicroelectronics, Inc. | Transistor with self-aligned source and drain contacts and method of making same |
-
2005
- 2005-05-20 EP EP10178251.4A patent/EP2259057B1/en not_active Revoked
- 2005-05-20 EP EP10177011.3A patent/EP2256494B1/en not_active Expired - Lifetime
- 2005-05-20 EP EP05755120A patent/EP1759201B1/en not_active Expired - Lifetime
- 2005-05-20 DE DE602005024133T patent/DE602005024133D1/de not_active Expired - Lifetime
- 2005-05-20 AT AT05755120T patent/ATE484745T1/de not_active IP Right Cessation
- 2005-05-20 CA CA2816310A patent/CA2816310C/en not_active Expired - Lifetime
- 2005-05-20 DK DK10177011.3T patent/DK2256494T3/en active
- 2005-05-20 EP EP10178254.8A patent/EP2256495B1/en not_active Expired - Lifetime
- 2005-05-20 JP JP2007515495A patent/JP5594935B2/ja not_active Expired - Fee Related
- 2005-05-20 DK DK10178251.4T patent/DK2259057T3/en active
- 2005-05-20 DK DK10178254.8T patent/DK2256495T3/en active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2256494B1 (en) | 2017-01-11 |
| DK2259057T3 (en) | 2016-05-09 |
| EP2259057B1 (en) | 2016-01-27 |
| DK2256495T3 (en) | 2015-11-09 |
| EP2256495B1 (en) | 2015-07-29 |
| ATE484745T1 (de) | 2010-10-15 |
| CA2816310C (en) | 2016-09-06 |
| EP2259057A1 (en) | 2010-12-08 |
| EP2256494A1 (en) | 2010-12-01 |
| JP2008501426A (ja) | 2008-01-24 |
| JP5594935B2 (ja) | 2014-09-24 |
| EP1759201B1 (en) | 2010-10-13 |
| EP2256495A3 (en) | 2011-03-23 |
| CA2816310A1 (en) | 2005-12-22 |
| EP1759201A2 (en) | 2007-03-07 |
| DE602005024133D1 (de) | 2010-11-25 |
| EP2256495A2 (en) | 2010-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2256494T3 (en) | System for monitoring physiological characteristics according to the user's biological condition | |
| US7399277B2 (en) | System for monitoring physiological characteristics | |
| US20080255438A1 (en) | System for monitoring physiological characteristics | |
| CA2550855C (en) | System for monitoring physiological characteristics | |
| US7022072B2 (en) | System for monitoring physiological characteristics | |
| US10080529B2 (en) | System for monitoring physiological characteristics | |
| US10448834B2 (en) | Smart messages and alerts for an infusion delivery and management system | |
| CN105899247A (zh) | 包括受控干预单元的用于注射泵单元的控制单元 | |
| CA2567711C (en) | System for monitoring physiological characteristics |